on JP Jenkins Ltd (isin : GB00BPLKLR77)
E-therapeutics Completes £28.90 Million Fundraise
e-therapeutics plc has announced the successful completion of a £28.90 million fundraise. The capital was raised through a subscription by M&G Investment Management Limited and Richard Griffiths, both existing shareholders. The completion of the fundraise followed clearance under the National Security and Investment Act 2021.
The proceeds will fund the advancement of multiple GalOmic™ pipeline assets towards clinical trials. Additionally, e-therapeutics plans to populate its early pipeline and enhance its AI systems on the HepNet™ platform. The company is also considering a future listing on NASDAQ.
Following the share allotment, e-therapeutics has 777,002,154 ordinary shares issued, each with voting rights.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all JP Jenkins Ltd news